Circulating Mycobiota Signatures and Cardiovascular Mortality among Patients Undergoing Hemodialysis

Affiliations

¹ Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee.
² Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, Tennessee.
³ Department of Nutritional Sciences, College of Agriculture and Life Science, University of Wisconsin-Madison, Madison, Wisconsin.
⁴ Department of Electrical Engineering and Computer Science, University of Tennessee, Knoxville, Tennessee.
⁵ Department of Surgery, School of Medicine, Transplant Research Institute, James D. Eason Transplant Institute, University of Tennessee Health Science Center, Memphis, Tennessee.
⁶ Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee.
⁷ Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota.
⁸ Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm, Sweden.
⁹ Department of Biostatistics, University of Florida, Gainesville, Florida.
¹⁰ Nephrology Section, Memphis VA Medical Center, Memphis, Tennessee.

Keiichi Sumida et al. J Am Soc Nephrol. 2025.

. 2025 Aug 11.

doi: 10.1681/ASN.0000000829. Online ahead of print.

¹ Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee.
² Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, Tennessee.
³ Department of Nutritional Sciences, College of Agriculture and Life Science, University of Wisconsin-Madison, Madison, Wisconsin.
⁴ Department of Electrical Engineering and Computer Science, University of Tennessee, Knoxville, Tennessee.
⁵ Department of Surgery, School of Medicine, Transplant Research Institute, James D. Eason Transplant Institute, University of Tennessee Health Science Center, Memphis, Tennessee.
⁶ Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee.
⁷ Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota.
⁸ Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm, Sweden.
⁹ Department of Biostatistics, University of Florida, Gainesville, Florida.
¹⁰ Nephrology Section, Memphis VA Medical Center, Memphis, Tennessee.

No abstract available

Keywords: ESKD; cardiovascular disease; hemodialysis; mortality risk; outcomes; risk factors; survival analysis.

References

1. Levey AS, Atkins R, Coresh J, et al. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007;72(3):247–259. doi: 10.1038/sj.ki.5002343 - DOI
1. Eckardt KU, Coresh J, Devuyst O, et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013;382(9887):158–169. doi: 10.1016/S0140-6736(13)60439-0 - DOI
1. Kooman JP, Kotanko P, Schols AM, Shiels PG, Stenvinkel P. Chronic kidney disease and premature ageing. Nat Rev Nephrol. 2014;10(12):732–742. doi: 10.1038/nrneph.2014.185 - DOI
1. Shiels PG, McGuinness D, Eriksson M, Kooman JP, Stenvinkel P. The role of epigenetics in renal ageing. Nat Rev Nephrol. 2017;13(8):471–482. doi: 10.1038/nrneph.2017.78 - DOI
1. Kooman JP, Dekker MJ, Usvyat LA, et al. Inflammation and premature aging in advanced chronic kidney disease. Am J Physiol Renal Physiol. 2017;313(4):F938–F950. doi: 10.1152/ajprenal.00256.2017 - DOI